Dr. Martens concedes that there will be some redundancies as it undertakes a reorganisation at EMEA regional level to simplify its operating model. Discussions are already in progress with employees who will be affected as certain positions are made redundant.
This comes as part of a longer-term transformation process, which was first shared in June ’25 as being necessary to strengthen the business’s position going forward. It aims to bring the business closer to consumers and individual markets, involving a move of some roles into group functions and others to individual markets.
For the ‘golden quarter’ Dr. Martens saw a seven per cent drop in direct-to-consumer sales and reported overall sales for the 13 weeks to December 28th, ’25 of £253 million, an overall 3.1 per cent fall year on year.
Ije Nwokerie, CEO, said: “We have continued to improve the quality of our revenue through a disciplined approach to promotions, and this represents a headwind to overall revenue, particularly eCommerce.”
Share